R/C IPRATROP DUO:Uses, Benefits, Dosage, Price & dosage,precautions..

R/C IPRATROP DUO

Ipratropium (40mcg)& Levo -Salbutamol Sulphate (100mcg)

R/C IPRATROP DUO combination of Ipratropium (40mcg) & Levo-Salbutamol Sulphate (100mcg), commonly referred to as R/C IPRATROP DUO, is a combination medication used in the treatment of respiratory conditions such as chronic obstructive pulmonary disease (COPD) and asthma. This formulation combines the bronchodilator effects of ipratropium and levo-salbutamol sulphate to provide relief from bronchospasm and improve lung function. In this article, we explore the uses, benefits, and mechanism of action of Ipratropium (40mcg) & Levo-Salbutamol Sulphate (100mcg).

Understanding Ipratropium (40mcg) & Levo-Salbutamol Sulphate (100mcg):

Ipratropium (40mcg) & Levo-Salbutamol Sulphate (100mcg) is a combination bronchodilator medication that works by relaxing the muscles in the airways and widening the bronchioles, making it easier to breathe. Ipratropium is an anticholinergic agent that blocks the action of acetylcholine, a neurotransmitter that causes bronchoconstriction. Levo-salbutamol sulphate, on the other hand, is a beta-adrenergic agonist that stimulates beta-2 adrenergic receptors in the lungs, leading to bronchodilation.

Key Benefits of Ipratropium (40mcg) & Levo-Salbutamol Sulphate (100mcg):

• Dual Action: This combination medication offers dual bronchodilation, targeting different pathways involved in airway constriction and inflammation.
• Fast Relief: Ipratropium (40mcg) & Levo-Salbutamol Sulphate (100mcg) provides rapid relief from respiratory symptoms, with onset of action within minutes of administration.
• Improved Lung Function: By opening up the airways, this medication improves overall lung function and respiratory efficiency, allowing for better oxygenation of the blood.

Clinical Uses of Ipratropium (40mcg) & Levo-Salbutamol Sulphate (100mcg):

• COPD Management: This medication is indicated for the maintenance treatment of bronchospasm associated with COPD, including chronic bronchitis and emphysema.
• Asthma Control: It is also used for the management of asthma, particularly in patients who require additional bronchodilation beyond what is provided by inhaled corticosteroids alone.
• Acute Respiratory Distress: Ipratropium (40mcg) & Levo-Salbutamol Sulphate (100mcg) can be administered during acute exacerbations of COPD or asthma to provide rapid relief from respiratory symptoms and improve lung function.

Dosage and Administration:

• Individualized Dosage: The recommended dosage of Ipratropium (40mcg) & Levo-Salbutamol Sulphate (100mcg) may vary depending on the severity of the patient's condition and their response to therapy.
• Inhalation: The medication is typically administered via inhalation using a suitable nebulizer device, with each treatment session lasting approximately 5-15 minutes.
• Frequency of Use: Patients may be instructed to use the medication as needed for symptom relief or on a regular schedule for maintenance therapy.

Safety Profile and Precautions:

• Common Side Effects: Common side effects of Ipratropium (40mcg) & Levo-Salbutamol Sulphate (100mcg) may include dry mouth, throat irritation, palpitations, tremor, and headache. 
• Cardiovascular Effects: Patients with pre-existing cardiovascular conditions may be at increased risk of experiencing exacerbations of tachycardia or arrhythmias while using this medication.
• Contraindications: Ipratropium (40mcg) & Levo-Salbutamol Sulphate (100mcg) is contraindicated in patients with a history of hypersensitivity to any of its components or to atropine or its derivatives.

Conclusion:

Ipratropium (40mcg) & Levo-Salbutamol Sulphate (100mcg), marketed as R/C IPRATROP DUO, is a valuable treatment option for patients with respiratory conditions such as COPD and asthma. By combining the bronchodilator effects of ipratropium and levo-salbutamol sulphate, this medication provides rapid relief from bronchospasm and improves overall lung function. However, it is essential to use Ipratropium (40mcg) & Levo-Salbutamol Sulphate (100mcg) cautiously, following prescribed dosages and safety precautions, to ensure optimal therapeutic outcomes and minimize the risk of adverse effectsSteris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488
BUY NOW